MC Plus Material – Overview of the FY2026 Medical Fee Revision: Inpatient Care (Common Matters) Page 16 – Center for Health Policy Information

Key News Points

The “MC Plus Material – Overview of the FY2026 Medical Fee Revision (Inpatient Care/Common Matters)” released by the Center for Health Policy Information suggests the importance of mid-to-long-term management and succession strategies, considering the revision cycle. Specifically, maintaining facility standards, achieving economies of scale by distributing the burden of capital investment, and utilizing tax incentives with a view to transitioning to specific medical corporations or social medical corporations are raised as points for discussion in medical M&A and business succession.

M&A Medical Editorial Department’s Perspective

The overview of the FY2026 medical fee revision, particularly the materials concerning “Inpatient Care (Common Matters),” is more than just an announcement of system changes for healthcare institution managers. This material suggests the necessity of business succession and M&A strategies that consider the revision cycle in terms of several years. For example, trends such as the further refinement of the per-DPC (Diagnosis Procedure Combination) payment system and the promotion of differentiation and collaboration of bed functions, which are likely to be indicated by the revision, can provide opportunities for hospitals with fragile management bases that find it difficult to cope alone to enjoy benefits such as maintaining facility standards through group affiliation or distributing the burden of new capital investments. Furthermore, M&A with a view to transitioning to social medical corporations or specific medical corporations can be an extremely effective option for building a sustainable medical care provision system by maximizing tax incentives.

Points Highlighted by This News

• Revision trends in the inpatient care domain encourage enhanced responsiveness to bed function differentiation and the DPC system, increasing the need for management stabilization through group affiliation.
• Maintaining facility standards and distributing capital investment burdens can be strong motivators for small-scale hospitals to consider joining a group.
• M&A with a view to transitioning to social medical corporations or specific medical corporations becomes a strategic option to maximize tax benefits.
• Early formulation of business succession and M&A plans, considering the mid-to-long-term revision cycle, is essential.

Practical Questions Arising from This News

• Based on the overview of the revision in the inpatient care domain, what facility standards should our institution consider maintaining going forward?
• What specific tax benefits can be expected from group affiliation?
• Given our institution’s size and current situation, is transitioning to a social medical corporation or a specific medical corporation a realistic option?

If You Feel “Should I Consult Too?”

If you have read the overview of the FY2026 medical fee revision, especially regarding “Inpatient Care (Common Matters),” and feel concerned about maintaining your institution’s facility standards or future capital investment burdens, it is worth considering whether M&A-driven group affiliation could be a solution. Also, if you are considering advancing business succession while enjoying tax benefits, consulting with experts is effective. To incorporate revision trends into your management and succession strategies early on, we recommend seeking advice from a professional perspective.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a completely success-fee-based structure as an M&A support institution certified by the Small and Medium Enterprise Agency. We handle consultations with strict confidentiality. Free consultation here